| Broad neutralization of SARS-related viruses by human monoclonal antibodies AZ Wec, D Wrapp, AS Herbert, DP Maurer, D Haslwanter, M Sakharkar, ... Science 369 (6504), 731-736, 2020 | 561 | 2020 |
| A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition ME Dieterle, D Haslwanter, RH Bortz, AS Wirchnianski, G Lasso, ... Cell host & microbe 28 (3), 486-496. e6, 2020 | 199 | 2020 |
| Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses AZ Wec, AS Herbert, CD Murin, EK Nyakatura, DM Abelson, JM Fels, ... Cell 169 (5), 878-890. e15, 2017 | 149 | 2017 |
| Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability X Zhao, KA Howell, S He, JM Brannan, AZ Wec, E Davidson, HL Turner, ... Cell 169 (5), 891-904. e15, 2017 | 108 | 2017 |
| Protocadherin-1 is essential for cell entry by New World hantaviruses RK Jangra, AS Herbert, R Li, LT Jae, LM Kleinfelter, MM Slough, ... Nature 563 (7732), 559-563, 2018 | 107 | 2018 |
| Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... ACS omega 6 (1), 85-102, 2020 | 83 | 2020 |
| Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever JM Fels, DP Maurer, AS Herbert, AS Wirchnianski, O Vergnolle, RW Cross, ... Cell 184 (13), 3486-3501. e21, 2021 | 49 | 2021 |
| Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC H ah Yoon, R Bartash, I Gendlina, J Rivera, A Nakouzi, RH Bortz III, ... JCI insight 6 (4), 2021 | 49 | 2021 |
| A combination of receptor-binding domain and N-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants D Haslwanter, ME Dieterle, AZ Wec, CM O’brien, M Sakharkar, C Florez, ... Mbio 12 (5), 10.1128/mbio. 02473-21, 2021 | 40* | 2021 |
| Calcium-dependent rubella virus fusion occurs in early endosomes M Dubé, L Etienne, M Fels, M Kielian Journal of virology 90 (14), 6303-6313, 2016 | 30 | 2016 |
| Real-time analysis of individual Ebola virus glycoproteins reveals pre-fusion, entry-relevant conformational dynamics ND Durham, AR Howard, R Govindan, F Senjobe, JM Fels, WE Diehl, ... Viruses 12 (1), 103, 2020 | 22 | 2020 |
| Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies AK Mishra, J Hellert, N Freitas, P Guardado-Calvo, A Haouz, JM Fels, ... Science 375 (6576), 104-109, 2022 | 21 | 2022 |
| Thorough investigation of a canine autoinflammatory disease (AID) confirms one main risk locus and suggests a modifier locus for amyloidosis M Olsson, L Tintle, M Kierczak, M Perloski, N Tonomura, A Lundquist, ... PLoS One 8 (10), e75242, 2013 | 18 | 2013 |
| Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes G Lasso, S Khan, SA Allen, M Mariano, C Florez, EP Orner, JA Quiroz, ... PLOS Computational Biology 18 (1), e1009778, 2022 | 15 | 2022 |
| Single-dilution COVID-19 antibody test with qualitative and quantitative readouts RH Bortz III, C Florez, E Laudermilch, AS Wirchnianski, G Lasso, ... Msphere 6 (2), 10.1128/msphere. 00224-21, 2021 | 14* | 2021 |
| A hyperstabilizing mutation in the base of the Ebola virus glycoprotein acts at multiple steps to abrogate viral entry JM Fels, JS Spence, RH Bortz III, ZA Bornholdt, K Chandran MBio 10 (4), 10.1128/mbio. 01408-19, 2019 | 12 | 2019 |
| Characterization of the SARS-CoV-2 S Protein: Biophysical NG Herrera, NC Morano, A Celikgil, GI Georgiev, RJ Malonis, JH Lee, ... Biochemical, Structural, and Antigenic Analysis. bioRxiv 2020 (14.150607), 2020 | 11 | 2020 |
| A glycoprotein mutation that emerged during the 2013–2016 Ebola virus epidemic alters proteolysis and accelerates membrane fusion JM Fels, RH Bortz III, T Alkutkar, E Mittler, RK Jangra, JS Spence, ... Mbio 12 (1), 10.1128/mbio. 03616-20, 2021 | 9 | 2021 |
| Exploiting pre-existing CD4+ T cell help from bacille calmette–guérin vaccination to improve antiviral antibody responses TW Ng, AS Wirchnianski, AZ Wec, JM Fels, CT Johndrow, KO Saunders, ... The Journal of Immunology 205 (2), 425-437, 2020 | 6 | 2020 |
| Genomic surveillance of SARS-CoV-2 in the Bronx enables clinical and epidemiological inference JM Fels, S Khan, R Forster, KA Skalina, S Sirichand, AS Fox, A Bergman, ... medRxiv, 2021.02. 08.21250641, 2021 | 2* | 2021 |
Kartik ChandranAlbert Einstein College of MedicineVerified email at einsteinmed.edu
